These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23273144)

  • 1. Superiority of ceftriaxon to cefazolin in a rat model of obstructive jaundice: an experimental study.
    Reyhan E; Duman M; Demirci Y; Atici AE; Ozer M; Cevreli B; Ekiz F; Dalgic T; Akoglu M; Genc E
    J Invest Surg; 2013 Feb; 26(1):11-5. PubMed ID: 23273144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ceftriaxone in malignant occlusive jaundice. Studies of serum and bile concentration in disordered bile excretion].
    Maikowski C; Rösch W; Sörgel F
    Fortschr Med; 1993 Nov; 111(32):513-6. PubMed ID: 8294078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of pregnancy on ceftriaxone, cefazolin and gentamicin pharmacokinetics in caesarean vs. non-pregnant sectioned women.
    Popović J; Grujić Z; Sabo A
    J Clin Pharm Ther; 2007 Dec; 32(6):595-602. PubMed ID: 18021337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary excretion and concentration of cefazolin.
    Ram MD; Watanatittan S
    Am J Gastroenterol; 1976 Dec; 66(6):540-5. PubMed ID: 1020741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of cephazolin, ceftazidime, and ceftriaxone distribution in nucleus pulposus.
    Yan D; Li J; Zhang Z; Zhu H
    Arch Orthop Trauma Surg; 2012 Jul; 132(7):969-73. PubMed ID: 22526195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ["Single shot" prevention in abdominal surgery. Antibiotics with long half-life (ceftriaxone, ornidazole) vs. antibiotics with short half-life (cefazolin, metronidazole, clindamycin)].
    Schweizer W; Striffeler H; Lüdi D; Fröscher R
    Helv Chir Acta; 1994 Apr; 60(4):483-8. PubMed ID: 8034522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cefazolin for prophylactic administration to dogs.
    Gonzalez OJ; Renberg WC; Roush JK; KuKanich B; Warner M
    Am J Vet Res; 2017 Jun; 78(6):695-701. PubMed ID: 28541147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of biliary disease on the excretion of cefazolin in human bile.
    McLeish AR; Strachan CJ; Powis SJ; Wise R; Bevan PG
    Surgery; 1977 Apr; 81(4):426-30. PubMed ID: 847650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased 3-gram cefazolin dosing for cesarean delivery prophylaxis in obese women.
    Swank ML; Wing DA; Nicolau DP; McNulty JA
    Am J Obstet Gynecol; 2015 Sep; 213(3):415.e1-8. PubMed ID: 26003059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide inhibits hepatic fibrosis, bile duct proliferation and bacterial translocation in obstructive jaundice.
    Türkçapar N; Bayar S; Koyuncu A; Ceyhan K
    Hepatogastroenterology; 2003; 50(51):680-3. PubMed ID: 12828059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefazolin tissue concentrations with a prophylactic dose administered before sleeve gastrectomy in obese patients: a single centre study in 116 patients.
    Cinotti R; Dumont R; Ronchi L; Roquilly A; Atthar V; Grégoire M; Planche L; Letessier E; Dailly E; Asehnoune K
    Br J Anaesth; 2018 Jun; 120(6):1202-1208. PubMed ID: 29793587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study on concentrations and pharmacokinetics of antibiotics in bile and evaluation of their microbicidal potential].
    Zheng J; Liang L; Wang Z; Peng B; Li S; Lai J
    Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):775-80. PubMed ID: 25573219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are first-generation cephalosporins obsolete? A retrospective, non-inferiority, cohort study comparing empirical therapy with cefazolin versus ceftriaxone for acute pyelonephritis in hospitalized patients.
    Hobbs AL; Shea KM; Daley MJ; Huth RG; Jaso TC; Bissett J; Hemmige V
    J Antimicrob Chemother; 2016 Jun; 71(6):1665-71. PubMed ID: 26983859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftriaxone versus cefazolin for prophylaxis in orthopedic surgery.
    Ramach W; Feichtinger J; Dallinger R; Nirnberger G
    J Chemother; 1989 Jul; 1(4 Suppl):1050-2. PubMed ID: 16312767
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of cefazolin prophylaxis in obese gravidae at time of cesarean delivery.
    Young OM; Shaik IH; Twedt R; Binstock A; Althouse AD; Venkataramanan R; Simhan HN; Wiesenfeld HC; Caritis SN
    Am J Obstet Gynecol; 2015 Oct; 213(4):541.e1-7. PubMed ID: 26103528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study of the biliary excretion of antibiotic (cefotiam) in the presence of biliary tract obstruction (author's transl)].
    Yoshikawa N; Tsuji Y; Sato Y; Ikeda Y; Shinada Y; Kawanishi N; Tamaki A; Kasai Y
    Jpn J Antibiot; 1979 Nov; 32(11):1101-6. PubMed ID: 513292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic-pharmacodynamic comparison of ceftriaxone regimens in acute cholangitis.
    Toki M; Yamaguchi Y; Goto T; Yoshida T; Ota H; Ochiai K; Gondo K; Watanabe S; Kurata I; Hisamatsu T
    J Infect Chemother; 2019 Oct; 25(10):780-785. PubMed ID: 31130393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial comparing ceftriaxone with cefazolin for antibiotic prophylaxis in abdominal hysterectomy.
    Phoolcharoen N; Nilgate S; Rattanapuntamanee O; Limpongsanurak S; Chaithongwongwatthana S
    Int J Gynaecol Obstet; 2012 Oct; 119(1):11-3. PubMed ID: 22789440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chorea-like symptoms and high blood concentration of ceftriaxone in a patient undergoing hemodialysis: A case report.
    Yokoyama Y; Hosokawa N; Kudo T; Goda H; Ito K; Suzuki M; Funakoshi R
    J Infect Chemother; 2020 Mar; 26(3):285-288. PubMed ID: 31680037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population Pharmacokinetics of Cefazolin in Serum and Adipose Tissue From Overweight and Obese Women Undergoing Cesarean Delivery.
    Grupper M; Kuti JL; Swank ML; Maggio L; Hughes BL; Nicolau DP
    J Clin Pharmacol; 2017 Jun; 57(6):712-719. PubMed ID: 27925657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.